Cumberland Pharmaceuticals (CPIX) Interest Expenses (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Interest Expenses of $85839.0 for Q1 2026, up 46.41% sequentially from $58629.0 in Q4 2025, and down 47.6% YoY from $163802.0 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Interest Expenses (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Interest Expenses for 17 years, with the latest figure at $85839.0 in Q1 2026.
- Quarterly Interest Expenses fell 47.6% year-over-year to $85839.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $495253.0 (down 20.82% YoY) and the FY2025 annual result came in at $495990.0, down 18.09% from the prior year.
- Interest Expenses grew to $85839.0 in Q1 2026 per CPIX's latest filing, from $58629.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $8.7 million in Q2 2024 and troughed at $58629.0 in Q4 2025.
- A 5-year average of $1.8 million and a median of $608015.0 in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2023 and 2025: Interest Expenses surged 1390.13% in 2023, then sank 95.12% in 2025.
- Over 5 years, Interest Expenses stood at $116622.0 in 2022, then soared by 35.54% to $158068.0 in 2023, then rose by 18.29% to $186983.0 in 2024, then tumbled by 68.64% to $58629.0 in 2025, then jumped by 46.41% to $85839.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $85839.0, $58629.0, and $2.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.16 Mn | 110.30 Mn | - | 724.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.98 Mn |
| Jun 30, 2026 | 6.98 Mn |
| Mar 31, 2026 | 85,839.00 |
| Mar 31, 2026 | 85,839.00 |
| Dec 31, 2025 | 58,629.00 |
| Dec 31, 2025 | 58,629.00 |
| Sep 30, 2025 | 2.61 Mn |
| Sep 30, 2025 | 2.61 Mn |
| Jun 30, 2025 | 740,791.00 |
| Jun 30, 2025 | 740,791.00 |
| Mar 31, 2025 | 163,802.00 |
| Mar 31, 2025 | 163,802.00 |
| Dec 31, 2024 | 186,983.00 |
| Dec 31, 2024 | 186,983.00 |
| Sep 30, 2024 | 8.49 Mn |
| Sep 30, 2024 | 8.49 Mn |
| Jun 30, 2024 | 8.70 Mn |
| Jun 30, 2024 | 8.70 Mn |
| Mar 31, 2024 | 3.36 Mn |
| Mar 31, 2024 | 3.36 Mn |